Advertisement

Pharmacy World & Science

, Volume 22, Issue 3, pp 109–115 | Cite as

Distribution of pharmaceuticals − a Norwegian logistic perspective

  • Jan Grund
  • Thor-Erik Vartdal
Article

Abstract

There is a general concern about rising costs of pharmaceutical expences. One political measure is a more efficient distribution system, which can take the form of new channels for retailing. In Norway mail-order pharmacy (MOP) has been brought to the agenda due to the recently proposed law regulating pharmacies (-Apoteklov-), market developments abroad, demand for self-medication, the increase in OTC-products and advances in information technology. Mail-order pharmacy involves direct delivery of medications through postal mail to patients or those responsible for dispensing medication. With reference to the USA, mail-order pharmacy has filled a niche in the market and several other countries are following. We are convinced that it is possible to maintain a high level of service quality in the sense of safety, councelling and compliance, and that there is a potential to develop a model for this distribution form in Norway. We believe that the actors in the Norwegian pharmaceutical market are better served in taking a more active role in this area and where possible initiating pilot projects in mail-order distribution. The pharmacists will continue to play an important role as a retail outlet and should, with their influence over patients, their knowledge and experience, contribute towards developing MOP to be a safe and complementary sales outlet. Developing such a solution demands the right balance between performance and quality on the one hand and efficiency on the other; two criteria, which we believe, do not contradict each other.

Logistics Mail-order pharmacy Pharmaceutical policy Pharmacy retailing Information technology E-commerce 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Grund J. The societal value of pharmaceuticals-balancing industrial and healthcare policy. PharmacoEconomics 1996;10:14-22.CrossRefPubMedGoogle Scholar
  2. 2.
    Norges offentlige utredninger (NOU). Rammevilkår for omsetning av legemidler. NOU 1997: 6, Elanders Publishing AS, Oslo 1997.Google Scholar
  3. 3.
    Grund J, Vartdal T-E. Postdistribusjon av legemidler – Diskusjon og modell. Discussion Paper No 17. Norwegian School of Management, Sandvika 1998.Google Scholar
  4. 4.
    Lambert DM, Stock JR. Strategic logistics management. 3rd ed. Boston: Irwin, 1993:4.Google Scholar
  5. 5.
    Christopher M. Logistics and supply chain management. Strategies for reducing costs and improving services. London: Pitman Publishing, 1992.Google Scholar
  6. 6.
    Scrip Magazine. Strategies for success in a world of giants. http://www.pjbpubs.co.uk/scrip/magx.html (29.4. 1998).Google Scholar
  7. 7.
    Andersson F. The distribution of pharmaceuticals in Europe-current and future trends in wholesaling. Health Policy 1994; 27:271-92.CrossRefPubMedGoogle Scholar
  8. 8.
    Chant DF. Mail-order pharmacy. Home Healthcare Nurse 1998;7:438-42.Google Scholar
  9. 9.
    Lawrence J. Does mail-order pharmacy really deliver the goods? Managed Care Magazine. http://www.managedcaremag.com/archiveMC/9806/9806.backlash.shtml (31.07.1998).Google Scholar
  10. 10.
    Shulman SR, Healy EM, Lasagna L. PBMs – reshaping the pharmaceutical distribution network. New York: The Pharmaceutical Products Press, 1998.Google Scholar
  11. 11.
    Scrip. Growth of US mail order pharmacy. Scrip No 2108, 5 March 1996.Google Scholar
  12. 12.
    Svensk Farmaceutisk Tidskrift. Debatt om postorderförsäljning i Holland. Svensk Farmaceutisk Tidskrift No 11, 1994.Google Scholar
  13. 13.
    Scrip. More mail order from UK to Germany. Scrip No 2166, 24 September 1996.Google Scholar
  14. 14.
    Scrip. UK pharmacist mail order case dismissed. Scrip No 2238, 6 June 1997.Google Scholar
  15. 15.
    Tüchsen H, Høst-Madsen K. Dansk medicinjagt på nettet. Børsen, 14 April 1999.Google Scholar
  16. 16.
    Sosial-og helsedepartementet. St.prp. nr. 1, 1997-98. Oslo 1997.Google Scholar
  17. 17.
    Høiness H. Internettapoteket selger til Norge. Dagbladet, 15 November 1996.Google Scholar
  18. 18.
    ApotekInfo. Farmateket satser på den nye apotekloven. Oslo:Nycomed Pharma Customer Newsletter No 1 1999.Google Scholar
  19. 19.
    Statens offentliga utredningar (SOU). Läkemedel i vård och handel-om en säker, flexibel och samordnad läkemedelsförsörjning. Betenkning av Läkemedelsdistributionsutredningen. SOU 1998: 28, Socialdepartementet, Stockholm 1998.Google Scholar
  20. 20.
    Grund J, Vartdal T-E. Smartkort som innsatsfaktor i helsetjenesten. Discussion Paper No 14. Norwegian School of Management, Sandvika 1998.Google Scholar
  21. 21.
    Sosial-og helsedepartementet. Om lov om apotek (apotekloven). Ny apoteklov som ledd i en samlet gjennomgang av legemiddelpolitikken. Ot prp nr 29 (1998-99). Oslo 1998.Google Scholar
  22. 22.
    Norwegian Board of Health. Hearing statesments to NOU 97:6. Oslo, 1997.Google Scholar
  23. 23.
    Palm E. Nett-apotek i Hammerfest? Finnmark Dagblad, 13 May 1998.Google Scholar
  24. 24.
    Sosial-og helsedepartementet. St.prp. nr. 1, 1995-96. Vedlegg til Sosial-og helsedepartementets budsjettproposisjon. Oslo 1995.Google Scholar
  25. 25.
    Ying LS, Peterson CR, Thielke TS, Siegler EE. Development of standards for providing prescription drugs by mail. American Journal of Health System Pharmacy (AJHP) 1993;50:85-91.Google Scholar
  26. 26.
    Birtcher KK, Shepherd MD. Users' Perceptions of Mail-Service Pharmacy. American Pharmacy 1992;12:35-41.CrossRefGoogle Scholar
  27. 27.
    Sosial-og helsedepartementet. Lov om apotek. Committee Hearings. Oslo: Helseavdelingen, 1998.Google Scholar
  28. 28.
    InteliHealth. More oversight for drugs on the net. http://www.intelihealth.com/IH/ihtIH (10.02.1999).Google Scholar
  29. 29.
    NTB. Helsetilsynet dropper legemiddeloversikt. Dagbladet, 9 May 1998.Google Scholar
  30. 30.
    Scrip. EC groups to look at e-commerce/adds. Scrip No 2482, 20 October 1999.Google Scholar
  31. 31.
    Nordic Council on Medicines. Marketing Pharmaceuticals on the Internet. NLN News 1999;4:1-4.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Jan Grund
    • 1
  • Thor-Erik Vartdal
    • 2
  1. 1.Norwegian School of ManagementSandvikaNorway
  2. 2.Ernst & Young ConsultingOsloNorway

Personalised recommendations